Company / Operating Income per Share
Viking Therapeutics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.53
FY2025
5-year range
-$3.53 / -$0.58
FY2021-FY2025
Trend
-133.9%
vs FY2024
Sector context
#152 of 201
Health Care
What the data says
Viking Therapeutics, Inc.'s operating income per share of $-3.53 is lower than 76% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-3.53 in FY2025 to $-0.36 in FY2019.
Based on SEC 10-K filings.
-3.53 in FY2025.
Declined from $-0.71 to $-3.53 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 201This company -$3.53 Sector average -$28.56
▼
+87.7% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 133.9% year-over-year.
- Ranks #152 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.53 | -133.9% |
| FY2024 | -$1.51 | -111.9% |
| FY2023 | -$0.71 | +0.0% |
| FY2022 | -$0.71 | -22.1% |
| FY2021 | -$0.58 | -29.1% |
| FY2020 | -$0.45 | -23.8% |
| FY2019 | -$0.36 | +31.5% |
| FY2018 | -$0.53 | +41.9% |
| FY2017 | -$0.92 | +26.1% |
| FY2016 | -$1.24 | +68.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026